Oncology Therapeutics Start-Up Oncologie Gets US$80M For Clinical-Stage Programs June 11, 2019

China and US-based oncology therapeutics start-up Oncologie announced on Monday that it has closed a US$80 million series B round of financing led by Hong Kong-based life sciences-focused investment firm Nan Fung Life Sciences, and Pivotal BioVentures Partners China, a member of Nan Fung Life Sciences. Chinese venture capital firm Volcanics Venture, investment firm Panacea […]

Oncology Therapeutics Start-Up Oncologie Gets US$80M For Clinical-Stage Programs comes originally from China Money Network. All Rights Reserved.